VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report)’s share price fell 16.7% during trading on Friday . The company traded as low as C$0.12 and last traded at C$0.13. 1,299,030 shares traded hands during trading, an increase of 389% from the average session volume of 265,597 shares. The stock had previously closed at C$0.15.
VentriPoint Diagnostics Price Performance
The company has a debt-to-equity ratio of -58.56, a current ratio of 0.28 and a quick ratio of 6.67. The stock has a market cap of C$18.65 million, a price-to-earnings ratio of -3.55 and a beta of 0.39. The stock has a fifty day moving average of C$0.10 and a 200 day moving average of C$0.13.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
See Also
- Five stocks we like better than VentriPoint Diagnostics
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- What is the NASDAQ Stock Exchange?
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- Investing in Construction Stocks
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
